Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial"

Circulation. 2024 Feb 27;149(9):727-728. doi: 10.1161/CIRCULATIONAHA.123.067368. Epub 2024 Feb 26.NO ABSTRACTPMID:38408147 | DOI:10.1161/CIRCULATIONAHA.123.067368

Source: Circulation - February 26, 2024 Category: Cardiology Authors: Frans Van de Werf Peter Sinnaeve Robert C Welsh Paul W Armstrong Source Type: research